¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Women's Rogaine Topical Solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • etching solution
    ºÎ½Ä¿ë¾×
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×
  • hypotonic solution
    ÀúÀå¾×
  • heavy solution
    Áß¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • isotonic solution
    µîÀå¾×
  • Lugol¡¯s solution
    ·ç°ñ¿ë¾×
  • maintenance solution
    À¯Áö¿ë¾×
  • molar solution
    ¸ô¾×
  • normal saline solution
    »ý¸®½Ä¿°¼ö
  • ophthalmic solution
    ¾È°ú¿ë¾×
  • physiological salt solution
    »ý¸®½Ä¿°¼ö
  • perfect solution
    ÀÌ»ó¿ë¾×, ¿ÏÀü¿ë¾×
  • regular solution
    Á¤±Ô¿ë¾×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • crystalloid solution
    Á¤Áú¾×
  • culture solution
    ¹è¾ç¾×
  • decontaminating solution
    ¿À¿°Á¦°Å¿ë¾×
  • disclosing solution
    Ä¡ÅÂÂø»ö¾×
  • equimolecular solution
    µîºÐÀÚ¿ë¾×
  • etching solution
    ºÎ½Ä¿ë¾×
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • heavy solution
    Áß¾×
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö
  • hyperbaric solution
    °íºñÁß¿ë¾×
  • hypertonic solution
    °íÀå¾×, ³ôÀº»ïÅõ¾Ð¿ë¾×
  • hypertonic salt solution
    °íÀå½Ä¿°¼ö
  • hypotonic solution
    ÀúÀå¾×, ³·Àº»ïÅõ¾Ð¿ë¾×
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö
  • iodine solution
    ¿ä¿Àµå¿ë¾×
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Lugols solution
    ·ç°ñ¾× (±×¶÷¿°»ö¿ë ¸Å¿°Á¦)
  • Ringer s solution
    ¸µ°Å¾×.
  • Ringers solution
    ¸µ°Å¾×
  • Tyrodes solution
    Ƽ·Îµå¾×
  • anisotonic solution
    ºñµîÀå¾×
  • aqueous solution
    ¼ö¾ç¾×(â©åÆäû)
  • aseptic solution
    ¹«±Õ¾×(¡­äû).
  • aseptic solution
    ¹«±Õ¾×(¡­¾×).
  • glycerin and potash solution
    ±Û¸®¼¼¸° Ä®·ý¾×.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • heavy solution
    Áß¾×(ñìäû).
  • hydrogen peroxide solution
    °ú»êÈ­¼ö¼Ò¼ö(Φ߫ûùâ©áÈ).
  • hypochromatosis =nuclear solution
    (ÇÙ)¿°Áú°¨¾à(ú·æøòõÊõå°) ÇÙºØA , ÇǺλö¼ÒÄ§Âø°¨¼ÒÁõ(ù«Ý±ßäáÈ ó·Êõá´ñø).
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö(î¸íåãÝç¤â©).
  • hypotonic solution
    ÀúÀ强¿ë¾×(î¸íåàõéÁäû).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • bleaching solution
    Ç¥¹é¿ë¾×.
  • boric acid solution
    ºØ»ê¼ö(ÝÝß«â©).
  • bromine solution
    ºê·Ò¿ë¾×(¡­éÁäû).
  • buffer solution
    ¿ÏÃæ¾×(èÐõúäû)
  • buffering solution
    ¿ÏÃæ¾×.
  • cardioplegic solution
    ½ÉÁ¤Áö¿ë¾×(ãýïÎò­éÂäû)
  • cardioplegic solution
    ½ÉÁ¤Áö¿ë¾×.
  • cetrimide-citrate-saline solution
    ¼¼Æ®¸®¹ÌÀ̵å-±¸¿¬»ê-½Ä¿° ¿ë¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×(¡­éÁäû), ±³Áú¿ë¾×
  • colloid solution
    ÄÝ·ÎÀ̵å¿ë¾×(¡­éÁäû).
  • conjugate solution
    ¦¿ë¾×(¡­éÁäû).
  • crystalloid solution
    Á¤Áú¾×.
  • crystalloid solution
    Á¤Áú¾×
  • culture solution
    ¹è¾ç¾×.
  • decontaminating solution
    Å»¿À¿°¿ë¾×
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • isosmotic solution
    µî»ïÅõ¾×(Ôõß¶÷âäû)
  • isotonic solution
    µîÀå¾×(Ôõíåäû)
  • Knop's solution
    Å©³ô¿ë¾×(éÁäû)
  • Krebs-Ringer solution
    Å©·¾½º-¸µ°Å ¿ë¾×(éÁäû)
  • Locke's solution
    ·Ï ¿ë¾×(éÁäû)
  • Lugol's solution
    ·ç°ñ ¿ë¾×(éÁäû)
  • molar solution
    ¸ô ¿ë¾×(éÁäû)
  • osmolal solution
    ¿À½º¸ô¶ö ¿ë¾×(éÁäû)
  • osmolar solution
    ¿À½º¸ô¶ó¸£ ¿ë¾×(éÁäû)
  • percent solution
    ÆÛ¼¾Æ® ¿ë¾×(éÁäû)
  • saturated solution
    Æ÷È­ ¿ë¾×(øéûùéÁäû)
  • solution
    ¿ë¾×(éÁäû)
  • solution hybridization
    ¿ë¾×(éÁäû) Æ¢±âÇü¼º(û¡à÷)
  • standard solution
    Ç¥ÁØ¿ë¾×(øöñÞéÁäû)
  • supersaturated solution
    °úÆ÷È­ ¿ë¾× (ΦøéûúéÁäû)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
HTDW heterosexual development of women
SFW sexual function of women; shell fragment wound; slow-filling wave
WIC walk-in clinic; women, infants, and children
WOU women's outpatient unit
WY women years
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
W women
BSS 3)balanced salt solution
EBSS Earl's balanced salt solution
ECS Euro Collins solution
FSCE Free Solution Capillary Electrophoresis
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • conjugate solution
    ¦ ¿ë¾×
  • developing solution
    Çö»ó ¾×
  • diluted ammonia solution
    Èñ¼® ¾Ï¸ð´Ï¾Æ¼ö
    ¹«»ö Åõ¸íÇÑ ¾ËÄ®¸®¼º ¿ë¾×. 100ml Áß¿¡ 9¡­10gÀÇ ¾Ï¸ð´Ï¾Æ¸¦ ÇÔÀ¯ÇÑ´Ù. Á¦¾à¿¡ ÇʼöÀûÀ¸·Î »ç¿ëµÈ´Ù.
  • disclosing solution
    Ä¡ÅÂ Âø»ö¾×
    Ä¡¾Æ Ç¥¸é¿¡ ¹ß¶ó¼­ ¼úÀÚ ¶Ç´Â ȯÀÚ°¡ ±× Ç¥¸é¿¡ ºÙ¾î ÀÖ´Â Ä¡¼®À̳ª ±âŸ Ä§Âø¹°À» º¼ ¼ö ÀÖµµ·Ï Á¶¼ºµÈ ¿ë¾×.
  • equimolecular solution
    µîºÐÀÚ ¿ë¾×
  • firing solution
    °íÁ¤¾×, Á¤Âø¾×
  • Harlmann sodium lactate solution
    Á¥»ê ³ªÆ®·ý ¿ë¾×, Çϸ£Æ®¸¸ ¿ë¾×, À¯»ê ³ªÆ®·ý ¿ë¾×
  • Hawship's solution
    ¾ÆÀÌ¾ä ¿ë¾×
  • hydrogen peroxide solution
    °ú»êÈ­ ¼ö¼Ò¼ö
  • hyperbaric solution
    °íºñÁß¾×
    ±âÁؾ׺¸´Ù ´õ Å« ºñÁßÀ» °®´Â ¿ë¾×. ¿¹¸¦ µé¸é ô¼ö ¸¶ÃëÁ¦·Î ô¼ö¾×ÀÇ ºñÁߺ¸´Ù Å« ºñÁßÀ» °®´Â ¾×ÀÌ ÁÖ»çµÇ¸é ÁÖ»ç ºÎÀ§ ¾Æ·¡ÂÊÀ¸·Î µµ´ÞÇÏ¿© ÀÌ ºÎÀ§°¡ ¸¶ÃëµÈ´Ù.
  • hypotonic salt solution
    ÀúÀå½Ä¿°¼ö
  • interstitial solid solution
    ħÀÔÇü °í¿ëü
    ¿ë¸Å ±Ý¼ÓÀÇ °áÁ¤°ÝÀÚ »çÀÌ¿¡ ¿ëÁú ¿øÀÚ°¡ µé¾î°£ ±¸Á¶ÀÇ °í¿ëü.
  • isotonic solution
    µîÀ强 ¿ë¾×, µîÀå¾×
  • lactated Ringer's solution
    À¯»êÀ» °¡ÇÑ ¸µ°Å ¾×
  • Naegeli's solution
    ³×°Ö¸® ¿ë¾×
    È¿¸ð, °õÆÎÀÌ µî¿¡ »ç¿ëÇÏ´Â Àΰø ¹èÁö·Î, ÀÌ¿°±â¼º Àλê Ä®·ý 0.2g, ¿°È­ Ä®½· 0.1g, ÁÖ¼®»ê ¾Ï¸ð´½ 10gÀ» ¹° 1,000cc¿¡ ³ìÀÎ °Í.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
topical anaesthesia Superficial loss of sensation in conjunctiva, mucous membranes or skin, produced by direct application of local anaesthetic solutions, ointments, or jellies.
(05 Mar 2000)
topical anaesthetic An anaesthetic that is applied or sprayed on the surface of the skin (or mucous membranes) for providing pain relief. Commonly used are benzocaine, butacaine, cyclomethycaine, lidocaine, tetracaine and dibucaine.
(27 Sep 1997)
topical antibiotics A ointment (or cream) based medication that kills bacteria.
Examples include Neosporin, Bactroban, Garamycin, bacitracin, gentamicin, mupirocin, neomycin, silver sulphasalazine, chloramphenicol and clindamycin.
(27 Sep 1997)
topical chemotherapy Treatment with anticancer drugs in a lotion or cream.
(12 Dec 1998)
fluorides, topical Fluorides, usually as pastes or gels, used for topical application to reduce the incidence of dental caries.
(12 Dec 1998)
acetic solution A vinegar.
(05 Mar 2000)
amaranth solution A 1% solution of amaranth (trisodium naphthol sulfonic acid), a synthetic vivid red dye, stable in acid and intensified in sodium hydroxide solution; used as a red or pink colourant in liquid pharmaceuticals.
(05 Mar 2000)
aqueous solution <chemistry> A solution in which water is the dissolving medium or solvent.
(09 Jan 1998)
barium solution A liquid containing barium sulfate, which shows up on X-rays. It outlines organs of the body so they can be seen on X-ray film.
(12 Dec 1998)
Benedict's solution <chemistry> An aqueous solution of sodium citrate, sodium carbonate, and copper sulfate which changes from its normal blue colour to orange, red, or yellow in the presence of a reducing sugar such as glucose.
See: Benedict's test for glucose.
(14 Aug 2000)
Burow's solution A preparation of aluminium subacetate and glacial acetic acid, used for its antiseptic and astringent action on the skin.
(05 Mar 2000)
Gallego's differentiating solution A dilute solution of formaldehyde and acetic acid used in a modified Gram stain to differentiate and enhance the basic fuchsin binding to Gram-negative microorganisms.
(05 Mar 2000)
Gey's solution A salt solution usually used in combination with naturally occurring body substances (e.g., blood serum, tissue extracts) and/or more complex chemically defined nutritive solution's for culturing animal cells.
(05 Mar 2000)
glucose solution, hypertonic Solution that is usually 10 percent glucose but may be higher. An isotonic solution of glucose is 5 percent.
(12 Dec 1998)
volumetric solution A solution made by mixing measured volumes of the components.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á